These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2471025)

  • 21. In-vivo immunomodulation by isoprinosine in patients with the acquired immunodeficiency syndrome and related complexes.
    Grieco MH; Reddy MM; Manvar D; Ahuja KK; Moriarty ML
    Ann Intern Med; 1984 Aug; 101(2):206-7. PubMed ID: 6204566
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum levels of IgG and IgA in rabbits immunostimulated with naganol and isoprinosine].
    Stoev K; Toshkov A; Georgiev D
    Acta Microbiol Bulg; 1984; 14():116-9. PubMed ID: 6204509
    [No Abstract]   [Full Text] [Related]  

  • 23. Inosine pranobex--is a single positive trial enough?
    Kweder SL; Schnur RA; Cooper EC
    N Engl J Med; 1990 Jun; 322(25):1807-9. PubMed ID: 1693175
    [No Abstract]   [Full Text] [Related]  

  • 24. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.
    Beran J; Špajdel M; Slíva J
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological effects of isoprinosine as a pulse immunotherapy in melanoma and ARC patients.
    Pompidou A; Soubrane C; Cour V; Telvi L; Meunier C; Jacquillat C
    Cancer Detect Prev Suppl; 1987; 1():457-62. PubMed ID: 2446759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy of genital warts with inosine pranobex and conventional treatment: double blind placebo controlled study.
    Davidson-Parker J; Dinsmore W; Khan MH; Hicks DA; Morris CA; Morris DF
    Genitourin Med; 1988 Dec; 64(6):383-6. PubMed ID: 2465265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex.
    Mindel A; Carney O; Sonnex C; Freris M; Patou G; Williams P
    Genitourin Med; 1989 Apr; 65(2):103-5. PubMed ID: 2473952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isoprinosine--a drug with antiviral and immunomodulating action].
    Deroń Z
    Wiad Lek; 1984 Sep; 37(17):1355-61. PubMed ID: 6084363
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of first-attack genital herpes--acyclovir versus inosine pranobex.
    Mindel A; Kinghorn G; Allason-Jones E; Woolley P; Barton I; Faherty A; Jeavons M; Williams P; Patou G
    Lancet; 1987 May; 1(8543):1171-3. PubMed ID: 2437417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A warning against exaggerated optimism about isoprinosine in HIV infection].
    Norrby R
    Lakartidningen; 1990 Aug; 87(32-33):2487-8. PubMed ID: 1697923
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunostimulation in the lymphadenopathy syndrome and in AIDS--Inosiplex (inosin pranobex, methisoprinol].
    Grossmann D; Behrens MI
    Onkologie; 1987 Jun; 10(3 Suppl):12-6. PubMed ID: 2443884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, virologic, and immunologic effects of combination therapy with ribavirin and isoprinosine in HIV-infected homosexual men.
    Schulof RS; Parenti DM; Simon GL; Paxton H; Meyer WA; Schlesselman SB; Courtless J; LeLacheur S; Sztein MB
    J Acquir Immune Defic Syndr (1988); 1990; 3(5):485-92. PubMed ID: 1691287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopotentiation of impaired lymphocyte functions in vitro by isoprinosine in prodromal subjects and AIDS patients.
    Tsang P; Lew F; O'Brien G; Selikoff IJ; Bekesi JG
    Int J Immunopharmacol; 1985; 7(4):511-4. PubMed ID: 2412972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Concepts of stimulating immunotherapy].
    Aiuti F; Montella F
    Minerva Med; 1982 Apr; 73(15):895-8. PubMed ID: 6176915
    [No Abstract]   [Full Text] [Related]  

  • 35. Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms.
    Pompidou A; Delsaux MC; Telvi L; Mace B; Coutance F; Falkenrodt A; Lang JM
    Cancer Res; 1985 Sep; 45(9 Suppl):4671s-4673s. PubMed ID: 2410111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS therapy.
    Stephens EJ
    N Z Med J; 1986 Feb; 99(795):72-3. PubMed ID: 2418393
    [No Abstract]   [Full Text] [Related]  

  • 37. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.
    You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F
    J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunopotentiation with methisoprinol in patients with non-Hodgkin's lymphoma].
    Fiedorowicz-Fabrycy I; Sochacka-Kuzko B; Urasiński I
    Pol Tyg Lek; 1985 Aug; 40(33):929-31. PubMed ID: 2414764
    [No Abstract]   [Full Text] [Related]  

  • 39. Study of the inhibition of histamine release by inosine pranobex.
    Ziesche R; Eichelberg D; Schmutzler W
    Agents Actions; 1987 Apr; 20(3-4):172-3. PubMed ID: 2440263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and immunological improvement of remittent multiple sclerosis by isoprinosine. Randomized pilot study].
    Pompidou A; Rancurel G; Delsaux MC; Telvi L; Cour V; Buge A
    Presse Med; 1986 May; 15(20):930-1. PubMed ID: 2424001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.